Skip to content
2000
Volume 15, Issue 6
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Uveitis refers to a group of ocular inflammatory diseases that can lead to blindness. For years, researchers have been trying to decipher the underlying mechanisms and develop therapeutic strategies using the model of experimental autoimmune uveitis (EAU). Recently, αA-crystallin has been found to be upregulated in EAU and can even ameliorate its severity through different mechanisms, suggesting its use as a potent therapeutic factor against uveitis. Here we review the protective role of αA-crystallin and discuss its functional mechanisms in EAU.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/1566524015666150731101146
2015-07-01
2025-06-19
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/1566524015666150731101146
Loading

  • Article Type:
    Research Article
Keyword(s): experimental autoimmune uveitis; gene therapy; uveitis; αA-crystallin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test